Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare.
The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry.
Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.
Despite the expected arrival of COVID-19 vaccines in just a few weeks, it could take several months — probably well into 2021 — before things get back to something close to normal in the United States.
American Airlines is expanding its COVID-19 pilot pre-flight testing program to London in an effort to get more international flyers in the sky.
AstraZeneca reported that its vaccine is 90% effective and cheaper to distribute than vaccines from its competitors. Meanwhile, the U.S. is averaging 1,500 deaths per day according to Johns Hopkins.
Pharmaceutical company AstraZeneca said Monday that late-stage trials showed its coronavirus vaccine was up to 90% effective, giving public health officials hope they may soon have access to a vaccine that is cheaper and easier to distribute than some of its rivals.
Pfizer said Friday it is asking U.S. regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic -- but not until after a long, hard winter.
A satellite jointly developed by Europe and the United States being launched this weekend will greatly help scientists keep track of the rise in global sea levels, one of the most daunting effects of climate change, a senior official at the European Space Agency said Friday.
The use of mRNA technology in COVID-19 vaccines is groundbreaking for a number of reasons. However, there is a drawback to the vaccines: they have to be stored in brutally cold temperatures.
The U.S. decline in cigarette smoking could be stalling while the adult vaping rate appears to be rising, according to a government report released Thursday.
The only known white giraffe in the world has been fitted with a GPS tracking device to help protect it from poachers as it grazes in Kenya.
Pfizer said Wednesday that new test results show its coronavirus vaccine is 95% effective, is safe and also protects older people most at risk of dying.
